- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MRK
Recent news which mentions MRK
FDA Drug Chief Tracey Hoeg Fired Days After After Marty Makary's Exit— Says Order Came From 'Way Above'
May 15, 2026
From Benzinga
From Motley Fool
From Motley Fool
From Benzinga
2 Dividend Stocks to Double Up On Right Now
May 08, 2026
From Motley Fool
Eli Lilly Now Has the World's Best-Selling Drug -- But Does That Make the Stock a No-Brainer Buy?
May 07, 2026
From Motley Fool
From Benzinga
From Motley Fool
From Benzinga
Summit, Akeso Report Lung Cancer Survival Boost With Ivonescimab, A Rival To Merck's Keytruda Multi-Billion Dollar Franchise, Says Analyst
August 27, 2025
From Benzinga
EU Rushes To Scrap Tariffs On US Goods To Unlock Lower American Auto Duties: These Exporters Stand To Gain Big
August 27, 2025
From Benzinga
From Benzinga
From Motley Fool
The Best Dividend Stocks To Buy Now
August 17, 2025
From TalkMarkets
Top Catalysts For DAX Index And Best Stocks Of 2025 Revealed
August 17, 2025
From TalkMarkets
2 Top Dividend Stocks to Buy on the Dip
August 16, 2025
From Motley Fool
Dividend Investor Earning $5,200 A Month Shares His Top 7 Stock Picks – 'Getting Dividend is the Biggest Joy in My Life'
August 14, 2025
From Benzinga
3 Magnificent S&P 500 Dividend Stocks Down Roughly 26% to 60% to Buy and Hold Forever
August 13, 2025
From Motley Fool
From Motley Fool
Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients
August 12, 2025
From Benzinga
IO Biotech's Combo Therapy For Skin Cancer Falls Just Short, Eyes FDA Talks Later This Year
August 11, 2025
From Benzinga
2 Magnificent Stocks to Buy That Are Near 52-Week Lows
August 10, 2025
From Motley Fool
3 High-Yield Healthcare Stocks to Buy Hand Over Fist in August
August 10, 2025
From Motley Fool
Is It Time to Buy Biotech Stocks?
August 06, 2025
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.